Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

GNLX stock hub

Genelux Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

GNLXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

138.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

GNLX

In the news

Latest news · GNLX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-127.3

P25 -105.6P50 -46.5P75 -3.1

ROIC-75.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All GNLX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

189

Groups with data

Currency

USD

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001231457
Company name	Genelux Corporation
Country	United States
Country code	US
Cusip	36870H103
Employees	26
Employees Change	2%
Employees Change Percent	8.33
Enterprise value	$114.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2023-01-26
Isin	US36870H1032
Last refreshed	2026-05-10
Market cap	$138.1M
Market cap category	Micro-Cap
Price	$3.11
Price currency	USD
Rev Per Employee	307.69x
Sector	Healthcare
Sic	2834
Symbol	GNLX
Website	https://www.genelux.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-24.31%
EV/Sales	14,299.71x
FCF yield	-20.19%
P/B ratio	6.03x
P/S ratio	17,263.96x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	$8,000
Gross Profit Growth3 Y	-91.07%
Net Income	$-33.6M
Net Income Growth Years	0%
Pretax Margin	-419,762.5%
Profit Per Employee	$-1.3M
ROA	-60.56
Roa5y	-68.2
ROCE	-137.7
ROE	-127.3
ROIC	-75.74

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	34.08%
Cagr3y	-50.39%
EPS Growth Quarters	2
EPS Growth Years	2
Revenue Growth Years	0x
Revenue Growth3 Y	-91.07x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0
Assets	$32.4M
Cash	$26.2M
Current Assets	$26.8M
Current Liabilities	$7.3M
Debt	$2.5M
Debt Equity	$0.11
Equity	$22.9M
Liabilities	$9.5M
Long Term Assets	$5.6M
Long Term Liabilities	$2.2M
Net Cash	$23.7M
Net Cash By Market Cap	$17.17
Net Cash Growth	-28.82%
Net Debt Equity	$-1.03
Tangible Book Value	$22.9M
Tangible Book Value Per Share	$0.52
WACC	6.85

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.68
Net Working Capital	$-6.4M
Quick ratio	3.6
Working Capital	$19.5M
Working Capital Turnover	$0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-17.97%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	34.05%
200-day SMA	3.8
3Y total return	-87.79%
50-day SMA	2.65
50-day SMA vs 200-day SMA	50under200
All Time High	40.98
All Time High Change	-92.41%
All Time High Date	2023-06-22
All Time Low	1.6
All Time Low Change	94.38%
All Time Low Date	2024-08-05
ATR	0.2
Beta	0.5
Beta1y	0.36
Beta2y	0.84
Ch YTD	-28.67
High	3.2
High52	8.54
High52 Date	2025-11-05
High52ch	-63.56%
Low	2.83
Low52	2.29
Low52 Date	2026-03-30
Low52ch	35.81%
Ma50ch	17.45%
Price vs 200-day SMA	-18.09%
RSI	67.7
RSI Monthly	48
RSI Weekly	48.78
Sharpe ratio	0.75x
Sortino ratio	1.14
Total Return	-17.97%
Tr YTD	-28.67
Tr1m	17.36%
Tr1w	13.5%
Tr3m	30.13%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	1
Analyst Price Target Top	$20
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.19
Operating Income	$-34.6M
Operating margin	-432,112.5
Price target	$17.25
Price Target Change	$455
Price Target Change Top	$543

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	36,183,581%
Float Percent	81.48%
Shares Insiders	9.01%
Shares Institutions	21.55%
Shares Out	44,408,910
Shares Qo Q	15.87%
Shares Yo Y	17.97%
Short Float	8.35%
Short Ratio	12.23
Short Shares	6.8

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-35.7M
Average Volume	161,445.15x
Bv Per Share	0.52
CAPEX	$-2M
Ch1m	17.36
Ch1w	13.5
Ch1y	34.05
Ch3m	30.13
Ch3y	-87.79
Ch6m	-42.62
Change	9.89%
Change From Open	9.12
Close	2.83
Days Gap	0.71
Depreciation Amortization	194,000
Dollar Volume	1,145,730.2
Earnings Date	2026-05-07
Earnings Time	amc
EBIT	$-34.6M
EBITDA	$-34.4M
EPS	$-0.85
F Score	1
FCF	$-27.9M
FCF EV Yield	-24.37x
FCF Per Share	$-0.63
Financing CF	18,866,000
Fiscal Year End	December
Founded	2,001
Investing CF	93,000
Ipr	-48.17
Iprfo	-48.17
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-19
Ma150	3.84
Ma150ch	-18.9%
Ma20	2.69
Ma20ch	15.61%
Net CF	-6,933,000
Next Earnings Date	2026-08-06
Open	2.85
Optionable	Yes
Position In Range	76
Post Close	3.11
Postmarket Change Percent	2.25
Postmarket Price	$3.18
Ppne	5,474,000
Price Date	2026-05-08
Ptbv Ratio	6.03
Relative Volume	2.28x
Revenue	8,000x
SBC By Revenue	97,800x
Share Based Comp	7,824,000
Tr6m	-42.62%
Us State	California
Volume	368,402

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does GNLX pay a dividend?

Capital-return profile for this ticker.

Performance

GNLX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns GNLX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+21.5%

Float: +81.5% of shares outstanding

Insider ownership

+9.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

GNLX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

67.7

Neutral momentum band

Price vs 200-day MA

-18.1%

50/200-day relationship not available

Beta (5Y)

0.50

Less volatile than the market

Sharpe ratio

0.75

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About GNLX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current GNLX stock rating?

Genelux Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full GNLX analysis?

The full report lives at /stocks/GNLX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for GNLX?

The latest report frames GNLX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the GNLX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.